• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

执行功能障碍会损害帕金森病患者的发音时机,而左旋多巴可改善这一情况。

Executive dysfunctions impair and levodopa improves articulatory timing in Parkinson's disease.

作者信息

Herbig Elisa, Mücke Doris, Barbe Michael T, Thies Tabea

机构信息

IfL-Phonetik, Faculty of Arts and Humanities, University of Cologne, Cologne, Germany.

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

出版信息

Front Hum Neurosci. 2025 Jul 2;19:1580376. doi: 10.3389/fnhum.2025.1580376. eCollection 2025.

DOI:10.3389/fnhum.2025.1580376
PMID:40672744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12263582/
Abstract

This study investigates the effects of executive functions and levodopa on articulatory timing patterns in simple and complex syllable onsets (CV vs. CCV) in Parkinson's disease (PD). Kinematic speech data (EMA) of 25 individuals with PD in medication-OFF as well as medication-ON condition and 25 healthy controls (HC) were recorded, and group differences were examined. Results showed preserved articulatory coordination that is skewed in time in the PD group as well as a positive effect of levodopa on these patterns. Cluster analysis revealed an age-dependent decline in executive functions across groups that correlated with the shift pattern of the second consonant in CCV sequences for the PD group. This indicates that executive dysfunctions could give rise to changes in articulatory timing patterns as the disease progresses but independently of general motor severity.

摘要

本研究调查了执行功能和左旋多巴对帕金森病(PD)患者简单和复杂音节起始(CV与CCV)时发音时间模式的影响。记录了25名处于未服药状态和服药状态的PD患者以及25名健康对照(HC)的运动语音数据(电磁发音仪),并检查了组间差异。结果显示,PD组存在发音协调性,且时间上有偏差,同时左旋多巴对这些模式有积极作用。聚类分析显示,各组执行功能随年龄下降,且与PD组CCV序列中第二个辅音的移位模式相关。这表明,随着疾病进展,执行功能障碍可能导致发音时间模式的改变,但与一般运动严重程度无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/c4e4073a8d18/fnhum-19-1580376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/43c0a7123948/fnhum-19-1580376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/497097dfc1c3/fnhum-19-1580376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/76a25e2d57c3/fnhum-19-1580376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/899bb1518bb9/fnhum-19-1580376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/c4e4073a8d18/fnhum-19-1580376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/43c0a7123948/fnhum-19-1580376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/497097dfc1c3/fnhum-19-1580376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/76a25e2d57c3/fnhum-19-1580376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/899bb1518bb9/fnhum-19-1580376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e37/12263582/c4e4073a8d18/fnhum-19-1580376-g005.jpg

相似文献

1
Executive dysfunctions impair and levodopa improves articulatory timing in Parkinson's disease.执行功能障碍会损害帕金森病患者的发音时机,而左旋多巴可改善这一情况。
Front Hum Neurosci. 2025 Jul 2;19:1580376. doi: 10.3389/fnhum.2025.1580376. eCollection 2025.
2
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.左旋多巴/卡比多巴肠凝胶对晚期帕金森病患者“关”期的长期影响:一项系统评价
Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.
3
Bromocriptine versus levodopa in early Parkinson's disease.早期帕金森病中溴隐亭与左旋多巴的对比
Cochrane Database Syst Rev. 2000(3):CD002258. doi: 10.1002/14651858.CD002258.
4
Ropinirole for levodopa-induced complications in Parkinson's disease.罗匹尼罗用于治疗帕金森病中左旋多巴引起的并发症。
Cochrane Database Syst Rev. 2001(1):CD001516. doi: 10.1002/14651858.CD001516.
5
Ropinirole for levodopa-induced complications in Parkinson's disease.罗匹尼罗用于治疗帕金森病中左旋多巴引起的并发症。
Cochrane Database Syst Rev. 2000(3):CD001516. doi: 10.1002/14651858.CD001516.
6
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.一种用于帕金森病灵敏且准确诊断的微创生物标志物。
medRxiv. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703.
7
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.对于帕金森病患者,在接受丘脑底核刺激后,抑郁症状会对患者报告的疾病严重程度产生负面影响。
J Parkinsons Dis. 2025 Jun 26:1877718X251354933. doi: 10.1177/1877718X251354933.
8
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.儿茶酚-O-甲基转移酶抑制剂与活性对照药治疗帕金森病左旋多巴诱发并发症的比较
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004553. doi: 10.1002/14651858.CD004553.pub2.
9
Helicobacter pylori eradication for Parkinson's disease.根除幽门螺杆菌治疗帕金森病。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008453. doi: 10.1002/14651858.CD008453.pub2.
10
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.

本文引用的文献

1
The Effects of Deep Brain Stimulation on Speech Motor Control in People With Parkinson's Disease.深部脑刺激对帕金森病患者言语运动控制的影响。
J Speech Lang Hear Res. 2023 Mar 7;66(3):804-819. doi: 10.1044/2022_JSLHR-22-00443. Epub 2023 Feb 13.
2
Speech dysfunction, cognition, and Parkinson's disease.言语障碍、认知与帕金森病。
Prog Brain Res. 2022;269(1):153-173. doi: 10.1016/bs.pbr.2022.01.017. Epub 2022 Feb 9.
3
Parkinson disease-associated cognitive impairment.帕金森病相关认知障碍。
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3.
4
Levodopa-Based Changes on Vocalic Speech Movements during Prosodic Prominence Marking.基于左旋多巴对韵律重音标记过程中元音语音运动的影响。
Brain Sci. 2021 May 4;11(5):594. doi: 10.3390/brainsci11050594.
5
Articulatory Correlates of Stress Pattern Disturbances in Talkers With Dysarthria.构音障碍者的重音模式障碍的发音相关因素。
J Speech Lang Hear Res. 2021 Jun 18;64(6S):2287-2300. doi: 10.1044/2021_JSLHR-20-00299. Epub 2021 May 13.
6
Levodopa challenge test: indications, protocol, and guide.左旋多巴激发试验:适应症、方案及指南。
J Neurol. 2021 Sep;268(9):3135-3143. doi: 10.1007/s00415-020-09810-7. Epub 2020 Apr 24.
7
Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.帕金森氏语音中的突出标记及其与运动表现和认知能力的相关性。
Neuropsychologia. 2020 Feb 3;137:107306. doi: 10.1016/j.neuropsychologia.2019.107306. Epub 2019 Dec 16.
8
Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language.帕金森病中的沟通障碍:运动和认知症状对言语和语言的影响。
Brain Lang. 2018 Oct;185:38-46. doi: 10.1016/j.bandl.2018.08.002. Epub 2018 Aug 6.
9
Cognitive training for freezing of gait in Parkinson's disease: a randomized controlled trial.帕金森病冻结步态的认知训练:一项随机对照试验。
NPJ Parkinsons Dis. 2018 May 18;4:15. doi: 10.1038/s41531-018-0052-6. eCollection 2018.
10
Impaired Feedforward Control and Enhanced Feedback Control of Speech in Patients with Cerebellar Degeneration.小脑变性患者言语的前馈控制受损及反馈控制增强
J Neurosci. 2017 Sep 20;37(38):9249-9258. doi: 10.1523/JNEUROSCI.3363-16.2017. Epub 2017 Aug 23.